Skip to main content

Recognizing benzodiazepine-induced neurological dysfunction

Tracking # 20-1304491

$99999.00

5 (1 ratings)
Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

0202-0000-25-182-H05-P - Benzodiazepine-induced neurological dysfunction (BIND) refers to cognitive impairment, memory deficits, increased fall risk, and potential neurodegenerative effects resulting from prolonged benzodiazepine use or withdrawal. Pharmacists play a critical role in identifying, preventing, and managing BIND to minimize patient harm, support safe deprescribing, and improve long-term cognitive outcomes. This Pharmacy Today CPE will provide pharmacists with a comprehensive understanding of BIND, including its risks, withdrawal effects, and evidence-based strategies for safer prescribing and deprescribing

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Pharmacy

Pharmacist

1h General

Learner Feedback